ResearchIn-Press PreviewHematologyOncology
Open Access | 
10.1172/jci.insight.199464
Deletion 9p drives B-ALL through the heterozygous inactivation of Pax5 and Cd72 in pre-leukemic cells
Belén Ruiz-Corzo,1 Ana Casado-García,1 Ninad Oak,2 Paula Somoza-Cotillas,1 Andrea López-Álvarez de Neyra,1 Jorge Martínez-Cano,3 Alba Pérez-Pons,4 Elena G. Sánchez,5 Oscar Blanco,6 Diego Alonso-López,7 Javier De Las Rivas,6 Susana Riesco,6 Pablo Prieto-Matos,6 Francisco Javier Garcia-Criado,6 Maria Begoña Garcia-Cenador,6 Alberto Orfao,4 Manuel Ramírez-Orellana,8 César Cobaleda,3 Carolina Vicente-Dueñas,6 Kim E. Nichols,2 and Isidro Sánchez-García1
1Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer, CSIC-USAL, Campus M. de Unamuno, Salamanca, Spain
2Department of Oncology, St. Jude Children's Research Hospital, Memphis, United States of America
3Immune System Development and Function Unit, Centro de Biología Molecular Severo Ochoa (Consejo Superior de Investigaciones Científicas -Universidad Autónoma de Madrid), Madrid, Spain
4Cancer Research Center (IBMCC, USAL-CSIC), Department of Medicine and Cytom, University of Salamanca, Biomedical Research Institute of Salamanca, Salamanca, Spain
5Oncohematology Laboratory, Advance Therapy Unit, Fundación para la Investigación Biomédica del Hospital Universitario Niño Jesús (FIB HUNJ), Madrid, Spain
6Institute of Biomedical Research of Salamanca (IBSAL), Universidad de Salamanca, Campus Miguel de Unamuno, Salamanca, Spain
7Bioinformatics Unit, Cancer Research Center (CSIC-USAL), Salamanca, Spain
8Department of Pediatric Hematology and Oncology, Hospital Infantil Universitario Niño Jesús Jesús & Institute of Biomedical Research Hospital Universitario La Princesa, Madrid, Spain
Find articles by Ruiz-Corzo, B. in: PubMed | Google Scholar
1Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer, CSIC-USAL, Campus M. de Unamuno, Salamanca, Spain
2Department of Oncology, St. Jude Children's Research Hospital, Memphis, United States of America
3Immune System Development and Function Unit, Centro de Biología Molecular Severo Ochoa (Consejo Superior de Investigaciones Científicas -Universidad Autónoma de Madrid), Madrid, Spain
4Cancer Research Center (IBMCC, USAL-CSIC), Department of Medicine and Cytom, University of Salamanca, Biomedical Research Institute of Salamanca, Salamanca, Spain
5Oncohematology Laboratory, Advance Therapy Unit, Fundación para la Investigación Biomédica del Hospital Universitario Niño Jesús (FIB HUNJ), Madrid, Spain
6Institute of Biomedical Research of Salamanca (IBSAL), Universidad de Salamanca, Campus Miguel de Unamuno, Salamanca, Spain
7Bioinformatics Unit, Cancer Research Center (CSIC-USAL), Salamanca, Spain
8Department of Pediatric Hematology and Oncology, Hospital Infantil Universitario Niño Jesús Jesús & Institute of Biomedical Research Hospital Universitario La Princesa, Madrid, Spain
Find articles by Casado-García, A. in: PubMed | Google Scholar
1Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer, CSIC-USAL, Campus M. de Unamuno, Salamanca, Spain
2Department of Oncology, St. Jude Children's Research Hospital, Memphis, United States of America
3Immune System Development and Function Unit, Centro de Biología Molecular Severo Ochoa (Consejo Superior de Investigaciones Científicas -Universidad Autónoma de Madrid), Madrid, Spain
4Cancer Research Center (IBMCC, USAL-CSIC), Department of Medicine and Cytom, University of Salamanca, Biomedical Research Institute of Salamanca, Salamanca, Spain
5Oncohematology Laboratory, Advance Therapy Unit, Fundación para la Investigación Biomédica del Hospital Universitario Niño Jesús (FIB HUNJ), Madrid, Spain
6Institute of Biomedical Research of Salamanca (IBSAL), Universidad de Salamanca, Campus Miguel de Unamuno, Salamanca, Spain
7Bioinformatics Unit, Cancer Research Center (CSIC-USAL), Salamanca, Spain
8Department of Pediatric Hematology and Oncology, Hospital Infantil Universitario Niño Jesús Jesús & Institute of Biomedical Research Hospital Universitario La Princesa, Madrid, Spain
Find articles by Oak, N. in: PubMed | Google Scholar
1Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer, CSIC-USAL, Campus M. de Unamuno, Salamanca, Spain
2Department of Oncology, St. Jude Children's Research Hospital, Memphis, United States of America
3Immune System Development and Function Unit, Centro de Biología Molecular Severo Ochoa (Consejo Superior de Investigaciones Científicas -Universidad Autónoma de Madrid), Madrid, Spain
4Cancer Research Center (IBMCC, USAL-CSIC), Department of Medicine and Cytom, University of Salamanca, Biomedical Research Institute of Salamanca, Salamanca, Spain
5Oncohematology Laboratory, Advance Therapy Unit, Fundación para la Investigación Biomédica del Hospital Universitario Niño Jesús (FIB HUNJ), Madrid, Spain
6Institute of Biomedical Research of Salamanca (IBSAL), Universidad de Salamanca, Campus Miguel de Unamuno, Salamanca, Spain
7Bioinformatics Unit, Cancer Research Center (CSIC-USAL), Salamanca, Spain
8Department of Pediatric Hematology and Oncology, Hospital Infantil Universitario Niño Jesús Jesús & Institute of Biomedical Research Hospital Universitario La Princesa, Madrid, Spain
Find articles by Somoza-Cotillas, P. in: PubMed | Google Scholar
1Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer, CSIC-USAL, Campus M. de Unamuno, Salamanca, Spain
2Department of Oncology, St. Jude Children's Research Hospital, Memphis, United States of America
3Immune System Development and Function Unit, Centro de Biología Molecular Severo Ochoa (Consejo Superior de Investigaciones Científicas -Universidad Autónoma de Madrid), Madrid, Spain
4Cancer Research Center (IBMCC, USAL-CSIC), Department of Medicine and Cytom, University of Salamanca, Biomedical Research Institute of Salamanca, Salamanca, Spain
5Oncohematology Laboratory, Advance Therapy Unit, Fundación para la Investigación Biomédica del Hospital Universitario Niño Jesús (FIB HUNJ), Madrid, Spain
6Institute of Biomedical Research of Salamanca (IBSAL), Universidad de Salamanca, Campus Miguel de Unamuno, Salamanca, Spain
7Bioinformatics Unit, Cancer Research Center (CSIC-USAL), Salamanca, Spain
8Department of Pediatric Hematology and Oncology, Hospital Infantil Universitario Niño Jesús Jesús & Institute of Biomedical Research Hospital Universitario La Princesa, Madrid, Spain
Find articles by López-Álvarez de Neyra, A. in: PubMed | Google Scholar
1Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer, CSIC-USAL, Campus M. de Unamuno, Salamanca, Spain
2Department of Oncology, St. Jude Children's Research Hospital, Memphis, United States of America
3Immune System Development and Function Unit, Centro de Biología Molecular Severo Ochoa (Consejo Superior de Investigaciones Científicas -Universidad Autónoma de Madrid), Madrid, Spain
4Cancer Research Center (IBMCC, USAL-CSIC), Department of Medicine and Cytom, University of Salamanca, Biomedical Research Institute of Salamanca, Salamanca, Spain
5Oncohematology Laboratory, Advance Therapy Unit, Fundación para la Investigación Biomédica del Hospital Universitario Niño Jesús (FIB HUNJ), Madrid, Spain
6Institute of Biomedical Research of Salamanca (IBSAL), Universidad de Salamanca, Campus Miguel de Unamuno, Salamanca, Spain
7Bioinformatics Unit, Cancer Research Center (CSIC-USAL), Salamanca, Spain
8Department of Pediatric Hematology and Oncology, Hospital Infantil Universitario Niño Jesús Jesús & Institute of Biomedical Research Hospital Universitario La Princesa, Madrid, Spain
Find articles by Martínez-Cano, J. in: PubMed | Google Scholar
1Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer, CSIC-USAL, Campus M. de Unamuno, Salamanca, Spain
2Department of Oncology, St. Jude Children's Research Hospital, Memphis, United States of America
3Immune System Development and Function Unit, Centro de Biología Molecular Severo Ochoa (Consejo Superior de Investigaciones Científicas -Universidad Autónoma de Madrid), Madrid, Spain
4Cancer Research Center (IBMCC, USAL-CSIC), Department of Medicine and Cytom, University of Salamanca, Biomedical Research Institute of Salamanca, Salamanca, Spain
5Oncohematology Laboratory, Advance Therapy Unit, Fundación para la Investigación Biomédica del Hospital Universitario Niño Jesús (FIB HUNJ), Madrid, Spain
6Institute of Biomedical Research of Salamanca (IBSAL), Universidad de Salamanca, Campus Miguel de Unamuno, Salamanca, Spain
7Bioinformatics Unit, Cancer Research Center (CSIC-USAL), Salamanca, Spain
8Department of Pediatric Hematology and Oncology, Hospital Infantil Universitario Niño Jesús Jesús & Institute of Biomedical Research Hospital Universitario La Princesa, Madrid, Spain
Find articles by Pérez-Pons, A. in: PubMed | Google Scholar
1Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer, CSIC-USAL, Campus M. de Unamuno, Salamanca, Spain
2Department of Oncology, St. Jude Children's Research Hospital, Memphis, United States of America
3Immune System Development and Function Unit, Centro de Biología Molecular Severo Ochoa (Consejo Superior de Investigaciones Científicas -Universidad Autónoma de Madrid), Madrid, Spain
4Cancer Research Center (IBMCC, USAL-CSIC), Department of Medicine and Cytom, University of Salamanca, Biomedical Research Institute of Salamanca, Salamanca, Spain
5Oncohematology Laboratory, Advance Therapy Unit, Fundación para la Investigación Biomédica del Hospital Universitario Niño Jesús (FIB HUNJ), Madrid, Spain
6Institute of Biomedical Research of Salamanca (IBSAL), Universidad de Salamanca, Campus Miguel de Unamuno, Salamanca, Spain
7Bioinformatics Unit, Cancer Research Center (CSIC-USAL), Salamanca, Spain
8Department of Pediatric Hematology and Oncology, Hospital Infantil Universitario Niño Jesús Jesús & Institute of Biomedical Research Hospital Universitario La Princesa, Madrid, Spain
Find articles by Sánchez, E. in: PubMed | Google Scholar
1Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer, CSIC-USAL, Campus M. de Unamuno, Salamanca, Spain
2Department of Oncology, St. Jude Children's Research Hospital, Memphis, United States of America
3Immune System Development and Function Unit, Centro de Biología Molecular Severo Ochoa (Consejo Superior de Investigaciones Científicas -Universidad Autónoma de Madrid), Madrid, Spain
4Cancer Research Center (IBMCC, USAL-CSIC), Department of Medicine and Cytom, University of Salamanca, Biomedical Research Institute of Salamanca, Salamanca, Spain
5Oncohematology Laboratory, Advance Therapy Unit, Fundación para la Investigación Biomédica del Hospital Universitario Niño Jesús (FIB HUNJ), Madrid, Spain
6Institute of Biomedical Research of Salamanca (IBSAL), Universidad de Salamanca, Campus Miguel de Unamuno, Salamanca, Spain
7Bioinformatics Unit, Cancer Research Center (CSIC-USAL), Salamanca, Spain
8Department of Pediatric Hematology and Oncology, Hospital Infantil Universitario Niño Jesús Jesús & Institute of Biomedical Research Hospital Universitario La Princesa, Madrid, Spain
Find articles by Blanco, O. in: PubMed | Google Scholar
1Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer, CSIC-USAL, Campus M. de Unamuno, Salamanca, Spain
2Department of Oncology, St. Jude Children's Research Hospital, Memphis, United States of America
3Immune System Development and Function Unit, Centro de Biología Molecular Severo Ochoa (Consejo Superior de Investigaciones Científicas -Universidad Autónoma de Madrid), Madrid, Spain
4Cancer Research Center (IBMCC, USAL-CSIC), Department of Medicine and Cytom, University of Salamanca, Biomedical Research Institute of Salamanca, Salamanca, Spain
5Oncohematology Laboratory, Advance Therapy Unit, Fundación para la Investigación Biomédica del Hospital Universitario Niño Jesús (FIB HUNJ), Madrid, Spain
6Institute of Biomedical Research of Salamanca (IBSAL), Universidad de Salamanca, Campus Miguel de Unamuno, Salamanca, Spain
7Bioinformatics Unit, Cancer Research Center (CSIC-USAL), Salamanca, Spain
8Department of Pediatric Hematology and Oncology, Hospital Infantil Universitario Niño Jesús Jesús & Institute of Biomedical Research Hospital Universitario La Princesa, Madrid, Spain
Find articles by Alonso-López, D. in: PubMed | Google Scholar
1Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer, CSIC-USAL, Campus M. de Unamuno, Salamanca, Spain
2Department of Oncology, St. Jude Children's Research Hospital, Memphis, United States of America
3Immune System Development and Function Unit, Centro de Biología Molecular Severo Ochoa (Consejo Superior de Investigaciones Científicas -Universidad Autónoma de Madrid), Madrid, Spain
4Cancer Research Center (IBMCC, USAL-CSIC), Department of Medicine and Cytom, University of Salamanca, Biomedical Research Institute of Salamanca, Salamanca, Spain
5Oncohematology Laboratory, Advance Therapy Unit, Fundación para la Investigación Biomédica del Hospital Universitario Niño Jesús (FIB HUNJ), Madrid, Spain
6Institute of Biomedical Research of Salamanca (IBSAL), Universidad de Salamanca, Campus Miguel de Unamuno, Salamanca, Spain
7Bioinformatics Unit, Cancer Research Center (CSIC-USAL), Salamanca, Spain
8Department of Pediatric Hematology and Oncology, Hospital Infantil Universitario Niño Jesús Jesús & Institute of Biomedical Research Hospital Universitario La Princesa, Madrid, Spain
Find articles by De Las Rivas, J. in: PubMed | Google Scholar
1Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer, CSIC-USAL, Campus M. de Unamuno, Salamanca, Spain
2Department of Oncology, St. Jude Children's Research Hospital, Memphis, United States of America
3Immune System Development and Function Unit, Centro de Biología Molecular Severo Ochoa (Consejo Superior de Investigaciones Científicas -Universidad Autónoma de Madrid), Madrid, Spain
4Cancer Research Center (IBMCC, USAL-CSIC), Department of Medicine and Cytom, University of Salamanca, Biomedical Research Institute of Salamanca, Salamanca, Spain
5Oncohematology Laboratory, Advance Therapy Unit, Fundación para la Investigación Biomédica del Hospital Universitario Niño Jesús (FIB HUNJ), Madrid, Spain
6Institute of Biomedical Research of Salamanca (IBSAL), Universidad de Salamanca, Campus Miguel de Unamuno, Salamanca, Spain
7Bioinformatics Unit, Cancer Research Center (CSIC-USAL), Salamanca, Spain
8Department of Pediatric Hematology and Oncology, Hospital Infantil Universitario Niño Jesús Jesús & Institute of Biomedical Research Hospital Universitario La Princesa, Madrid, Spain
Find articles by Riesco, S. in: PubMed | Google Scholar
1Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer, CSIC-USAL, Campus M. de Unamuno, Salamanca, Spain
2Department of Oncology, St. Jude Children's Research Hospital, Memphis, United States of America
3Immune System Development and Function Unit, Centro de Biología Molecular Severo Ochoa (Consejo Superior de Investigaciones Científicas -Universidad Autónoma de Madrid), Madrid, Spain
4Cancer Research Center (IBMCC, USAL-CSIC), Department of Medicine and Cytom, University of Salamanca, Biomedical Research Institute of Salamanca, Salamanca, Spain
5Oncohematology Laboratory, Advance Therapy Unit, Fundación para la Investigación Biomédica del Hospital Universitario Niño Jesús (FIB HUNJ), Madrid, Spain
6Institute of Biomedical Research of Salamanca (IBSAL), Universidad de Salamanca, Campus Miguel de Unamuno, Salamanca, Spain
7Bioinformatics Unit, Cancer Research Center (CSIC-USAL), Salamanca, Spain
8Department of Pediatric Hematology and Oncology, Hospital Infantil Universitario Niño Jesús Jesús & Institute of Biomedical Research Hospital Universitario La Princesa, Madrid, Spain
Find articles by Prieto-Matos, P. in: PubMed | Google Scholar
1Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer, CSIC-USAL, Campus M. de Unamuno, Salamanca, Spain
2Department of Oncology, St. Jude Children's Research Hospital, Memphis, United States of America
3Immune System Development and Function Unit, Centro de Biología Molecular Severo Ochoa (Consejo Superior de Investigaciones Científicas -Universidad Autónoma de Madrid), Madrid, Spain
4Cancer Research Center (IBMCC, USAL-CSIC), Department of Medicine and Cytom, University of Salamanca, Biomedical Research Institute of Salamanca, Salamanca, Spain
5Oncohematology Laboratory, Advance Therapy Unit, Fundación para la Investigación Biomédica del Hospital Universitario Niño Jesús (FIB HUNJ), Madrid, Spain
6Institute of Biomedical Research of Salamanca (IBSAL), Universidad de Salamanca, Campus Miguel de Unamuno, Salamanca, Spain
7Bioinformatics Unit, Cancer Research Center (CSIC-USAL), Salamanca, Spain
8Department of Pediatric Hematology and Oncology, Hospital Infantil Universitario Niño Jesús Jesús & Institute of Biomedical Research Hospital Universitario La Princesa, Madrid, Spain
Find articles by Garcia-Criado, F. in: PubMed | Google Scholar
1Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer, CSIC-USAL, Campus M. de Unamuno, Salamanca, Spain
2Department of Oncology, St. Jude Children's Research Hospital, Memphis, United States of America
3Immune System Development and Function Unit, Centro de Biología Molecular Severo Ochoa (Consejo Superior de Investigaciones Científicas -Universidad Autónoma de Madrid), Madrid, Spain
4Cancer Research Center (IBMCC, USAL-CSIC), Department of Medicine and Cytom, University of Salamanca, Biomedical Research Institute of Salamanca, Salamanca, Spain
5Oncohematology Laboratory, Advance Therapy Unit, Fundación para la Investigación Biomédica del Hospital Universitario Niño Jesús (FIB HUNJ), Madrid, Spain
6Institute of Biomedical Research of Salamanca (IBSAL), Universidad de Salamanca, Campus Miguel de Unamuno, Salamanca, Spain
7Bioinformatics Unit, Cancer Research Center (CSIC-USAL), Salamanca, Spain
8Department of Pediatric Hematology and Oncology, Hospital Infantil Universitario Niño Jesús Jesús & Institute of Biomedical Research Hospital Universitario La Princesa, Madrid, Spain
Find articles by Garcia-Cenador, M. in: PubMed | Google Scholar
1Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer, CSIC-USAL, Campus M. de Unamuno, Salamanca, Spain
2Department of Oncology, St. Jude Children's Research Hospital, Memphis, United States of America
3Immune System Development and Function Unit, Centro de Biología Molecular Severo Ochoa (Consejo Superior de Investigaciones Científicas -Universidad Autónoma de Madrid), Madrid, Spain
4Cancer Research Center (IBMCC, USAL-CSIC), Department of Medicine and Cytom, University of Salamanca, Biomedical Research Institute of Salamanca, Salamanca, Spain
5Oncohematology Laboratory, Advance Therapy Unit, Fundación para la Investigación Biomédica del Hospital Universitario Niño Jesús (FIB HUNJ), Madrid, Spain
6Institute of Biomedical Research of Salamanca (IBSAL), Universidad de Salamanca, Campus Miguel de Unamuno, Salamanca, Spain
7Bioinformatics Unit, Cancer Research Center (CSIC-USAL), Salamanca, Spain
8Department of Pediatric Hematology and Oncology, Hospital Infantil Universitario Niño Jesús Jesús & Institute of Biomedical Research Hospital Universitario La Princesa, Madrid, Spain
Find articles by Orfao, A. in: PubMed | Google Scholar
1Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer, CSIC-USAL, Campus M. de Unamuno, Salamanca, Spain
2Department of Oncology, St. Jude Children's Research Hospital, Memphis, United States of America
3Immune System Development and Function Unit, Centro de Biología Molecular Severo Ochoa (Consejo Superior de Investigaciones Científicas -Universidad Autónoma de Madrid), Madrid, Spain
4Cancer Research Center (IBMCC, USAL-CSIC), Department of Medicine and Cytom, University of Salamanca, Biomedical Research Institute of Salamanca, Salamanca, Spain
5Oncohematology Laboratory, Advance Therapy Unit, Fundación para la Investigación Biomédica del Hospital Universitario Niño Jesús (FIB HUNJ), Madrid, Spain
6Institute of Biomedical Research of Salamanca (IBSAL), Universidad de Salamanca, Campus Miguel de Unamuno, Salamanca, Spain
7Bioinformatics Unit, Cancer Research Center (CSIC-USAL), Salamanca, Spain
8Department of Pediatric Hematology and Oncology, Hospital Infantil Universitario Niño Jesús Jesús & Institute of Biomedical Research Hospital Universitario La Princesa, Madrid, Spain
Find articles by
Ramírez-Orellana, M.
in:
PubMed
|
Google Scholar
|
1Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer, CSIC-USAL, Campus M. de Unamuno, Salamanca, Spain
2Department of Oncology, St. Jude Children's Research Hospital, Memphis, United States of America
3Immune System Development and Function Unit, Centro de Biología Molecular Severo Ochoa (Consejo Superior de Investigaciones Científicas -Universidad Autónoma de Madrid), Madrid, Spain
4Cancer Research Center (IBMCC, USAL-CSIC), Department of Medicine and Cytom, University of Salamanca, Biomedical Research Institute of Salamanca, Salamanca, Spain
5Oncohematology Laboratory, Advance Therapy Unit, Fundación para la Investigación Biomédica del Hospital Universitario Niño Jesús (FIB HUNJ), Madrid, Spain
6Institute of Biomedical Research of Salamanca (IBSAL), Universidad de Salamanca, Campus Miguel de Unamuno, Salamanca, Spain
7Bioinformatics Unit, Cancer Research Center (CSIC-USAL), Salamanca, Spain
8Department of Pediatric Hematology and Oncology, Hospital Infantil Universitario Niño Jesús Jesús & Institute of Biomedical Research Hospital Universitario La Princesa, Madrid, Spain
Find articles by Cobaleda, C. in: PubMed | Google Scholar
1Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer, CSIC-USAL, Campus M. de Unamuno, Salamanca, Spain
2Department of Oncology, St. Jude Children's Research Hospital, Memphis, United States of America
3Immune System Development and Function Unit, Centro de Biología Molecular Severo Ochoa (Consejo Superior de Investigaciones Científicas -Universidad Autónoma de Madrid), Madrid, Spain
4Cancer Research Center (IBMCC, USAL-CSIC), Department of Medicine and Cytom, University of Salamanca, Biomedical Research Institute of Salamanca, Salamanca, Spain
5Oncohematology Laboratory, Advance Therapy Unit, Fundación para la Investigación Biomédica del Hospital Universitario Niño Jesús (FIB HUNJ), Madrid, Spain
6Institute of Biomedical Research of Salamanca (IBSAL), Universidad de Salamanca, Campus Miguel de Unamuno, Salamanca, Spain
7Bioinformatics Unit, Cancer Research Center (CSIC-USAL), Salamanca, Spain
8Department of Pediatric Hematology and Oncology, Hospital Infantil Universitario Niño Jesús Jesús & Institute of Biomedical Research Hospital Universitario La Princesa, Madrid, Spain
Find articles by Vicente-Dueñas, C. in: PubMed | Google Scholar
1Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer, CSIC-USAL, Campus M. de Unamuno, Salamanca, Spain
2Department of Oncology, St. Jude Children's Research Hospital, Memphis, United States of America
3Immune System Development and Function Unit, Centro de Biología Molecular Severo Ochoa (Consejo Superior de Investigaciones Científicas -Universidad Autónoma de Madrid), Madrid, Spain
4Cancer Research Center (IBMCC, USAL-CSIC), Department of Medicine and Cytom, University of Salamanca, Biomedical Research Institute of Salamanca, Salamanca, Spain
5Oncohematology Laboratory, Advance Therapy Unit, Fundación para la Investigación Biomédica del Hospital Universitario Niño Jesús (FIB HUNJ), Madrid, Spain
6Institute of Biomedical Research of Salamanca (IBSAL), Universidad de Salamanca, Campus Miguel de Unamuno, Salamanca, Spain
7Bioinformatics Unit, Cancer Research Center (CSIC-USAL), Salamanca, Spain
8Department of Pediatric Hematology and Oncology, Hospital Infantil Universitario Niño Jesús Jesús & Institute of Biomedical Research Hospital Universitario La Princesa, Madrid, Spain
Find articles by
Nichols, K.
in:
PubMed
|
Google Scholar
|
1Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer, CSIC-USAL, Campus M. de Unamuno, Salamanca, Spain
2Department of Oncology, St. Jude Children's Research Hospital, Memphis, United States of America
3Immune System Development and Function Unit, Centro de Biología Molecular Severo Ochoa (Consejo Superior de Investigaciones Científicas -Universidad Autónoma de Madrid), Madrid, Spain
4Cancer Research Center (IBMCC, USAL-CSIC), Department of Medicine and Cytom, University of Salamanca, Biomedical Research Institute of Salamanca, Salamanca, Spain
5Oncohematology Laboratory, Advance Therapy Unit, Fundación para la Investigación Biomédica del Hospital Universitario Niño Jesús (FIB HUNJ), Madrid, Spain
6Institute of Biomedical Research of Salamanca (IBSAL), Universidad de Salamanca, Campus Miguel de Unamuno, Salamanca, Spain
7Bioinformatics Unit, Cancer Research Center (CSIC-USAL), Salamanca, Spain
8Department of Pediatric Hematology and Oncology, Hospital Infantil Universitario Niño Jesús Jesús & Institute of Biomedical Research Hospital Universitario La Princesa, Madrid, Spain
Find articles by Sánchez-García, I. in: PubMed | Google Scholar
Published February 17, 2026 - More info
Copyright © 2026, Ruiz-Corzo et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
